We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.15B
AUM Growth
-$253M
Cap. Flow
-$97.3M
Cap. Flow %
-8.43%
Top 10 Hldgs %
65.98%
Holding
89
New
12
Increased
29
Reduced
25
Closed
19

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$63.1M
2
NTRA icon
Natera
NTRA
+$45.2M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$26.6M
4
ILMN icon
Illumina
ILMN
+$14.6M
5
MCRB icon
Seres Therapeutics
MCRB
+$9.91M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$67.4M
2
AVTR icon
Avantor
AVTR
+$28M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$21.6M
4
ARGX icon
argenx
ARGX
+$16.9M
5
FATE icon
Fate Therapeutics
FATE
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 72.39%
2 Miscellaneous 27.61%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDX icon
76
CALL
Celldex Therapeutics
CLDX
$3.07B
– –
-191,600
Closed -$5.17M
CLDX icon
77
PUT
Celldex Therapeutics
CLDX
$3.07B
– –
-60,600
Closed -$1.63M
DXCM icon
78
DexCom
DXCM
$34.3B
– –
-14,468
Closed -$1.08M
FOLD
79
DELISTED
Amicus Therapeutics
FOLD
– –
-478,245
Closed -$5.14M
HQY icon
80
HealthEquity
HQY
$7.97B
– –
-127,043
Closed -$7.8M
IWM icon
81
PUT
iShares Russell 2000 ETF
IWM
$80.8B
– –
-50,000
Closed -$8.47M
MASI
82
DELISTED
Masimo
MASI
– –
-5,984
Closed -$782K
QGEN icon
83
Qiagen
QGEN
$8.9B
– –
-179,093
Closed -$8.96M
SPY icon
84
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
– –
-465,000
Closed -$175M
TNDM icon
85
Tandem Diabetes Care
TNDM
$1.49B
– –
-256,268
Closed -$15.2M
ZNTL icon
86
Zentalis Pharmaceuticals
ZNTL
$360M
– –
-38,342
Closed -$1.08M
RCM
87
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-590,819
Closed -$12.4M
SWAV
88
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-3,300
Closed -$631K
RDUS
89
DELISTED
Radius Health, Inc.
RDUS
– –
-502,587
Closed -$5.21M
1 2 3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Eversept Partners held 89 positions worth $1.15B, down 18% from $1.41B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Eversept Partners withdrew a net $97.3M in Q3 2022, closing 19 positions and reducing 25 holdings. Its most notable exit was AstraZeneca, an estimated $67.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 70% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Eversept Partners opened a new position in Seres Therapeutics worth $12.4M.

  • Eversept Partners's largest Q3 2022 buy was Seres Therapeutics: 96,791 shares worth $12.4M.
  • Eversept Partners added most to GSK in Q3 2022, an estimated $63.1M increase.
  • Eversept Partners's biggest Q3 2022 reduction was Avantor, cutting an estimated $28M.
  • Eversept Partners fully exited AstraZeneca in Q3 2022, selling an estimated $67.4M.
  • Eversept Partners's ten largest holdings make up 66% of its $1.15B portfolio in Q3 2022.
  • Eversept Partners opened 12 new positions and closed 19 in Q3 2022.
  • Eversept Partners's portfolio value fell 18% quarter-over-quarter to $1.15B.

Based on Eversept Partners's 13F filing for Q3 2022, filed 14 Nov 2022.